Trials / Completed
CompletedNCT05629520
A Neurobiological Model of Anhedonia
Inflammatory, Behavioral and Neural Markers of Anhedonia in Major Depressive Disorder
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Milton S. Hershey Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to better understand anhedonia in Major Depressive Disorder by investigating the reward-related neural and inflammatory correlates.
Detailed description
Background: Despite extensive research on the treatment of Major Depressive Disorder (MDD) relapse rates are as high as 80%. Of those, 30-40% fall into the severe spectrum called treatment resistant depression (TRD) as they fail to respond to at least two lines of antidepressant treatment interventions. TRD has been linked with anhedonia, the inability to experience pleasure or interest in usually enjoyable activities. The neurobiology of anhedonia is poorly understood with recent literature examining an inflammatory association and linking it to deficits in reward-related brain circuitry. The present study examines neurobiological correlates of anhedonia in MDD and TRD, specifically C-Reactive Protein (CRP), IL-6 and ventral striatal (VS) activity. The study also explores whether VS activity mediates the association between inflammation and anhedonia.
Conditions
Timeline
- Start date
- 2020-02-19
- Primary completion
- 2024-07-30
- Completion
- 2024-07-30
- First posted
- 2022-11-29
- Last updated
- 2024-10-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05629520. Inclusion in this directory is not an endorsement.